Home/VLP Therapeutics/Wataru Akahata
WA

Wataru Akahata

Co-Founder, Scientific Leader

VLP Therapeutics

VLP Therapeutics Pipeline

DrugIndicationPhase
VLPCOV-02COVID-19 (booster)Phase 1/2
Malaria VaccineMalaria preventionPre-clinical
Dengue VaccineDengue fever preventionPre-clinical
Cancer VaccineOncology (unspecified)Pre-clinical